APA (7th ed.) Citation

Zhang, Y., Ren, Y., Dong, G., Jiao, Q., Guo, N., Gao, P., . . . Zhao, W. (2024). TEAD2 Promotes Hepatocellular Carcinoma Development and Sorafenib Resistance via TAK1 Transcriptional Activation. Molecular cancer research, 22(12), 1102-1116. https://doi.org/10.1158/1541-7786.MCR-24-0060

Chicago Style (17th ed.) Citation

Zhang, Yahui, Yidan Ren, Guoying Dong, Qinlian Jiao, Nan Guo, Ping Gao, Ya Li, Yunshan Wang, and Wei Zhao. "TEAD2 Promotes Hepatocellular Carcinoma Development and Sorafenib Resistance via TAK1 Transcriptional Activation." Molecular Cancer Research 22, no. 12 (2024): 1102-1116. https://doi.org/10.1158/1541-7786.MCR-24-0060.

MLA (9th ed.) Citation

Zhang, Yahui, et al. "TEAD2 Promotes Hepatocellular Carcinoma Development and Sorafenib Resistance via TAK1 Transcriptional Activation." Molecular Cancer Research, vol. 22, no. 12, 2024, pp. 1102-1116, https://doi.org/10.1158/1541-7786.MCR-24-0060.